Brisbane biotech secures $14 mn for drug discovery

Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...

July 10, 2013 | Wednesday | News
NZ firm migrates to Aus to capitalize on MS drug

Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...

September 11, 2013 | Wednesday | News
Dengue incurs annual cost of $950 mn to SE Asia

Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east A...

June 20, 2014 | Friday | Analysis
NSC lung cancer drug pipeline is strong: Analyst

Singapore: Non-Small Cell Lung Cancer (NSCLC) treatment pipeline has a diverse selection of 122 first-in-class products ...

November 11, 2014 | Tuesday | Analysis
Are declining Ebola cases a challenge for clinical studies?

Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...

March 16, 2015 | Monday | Analysis
BMS releases $3.5 mn fund for Hep B&C in India, China

Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...

December 4, 2014 | Thursday | News
AMRI acquires Cedarburg at $41mn

Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...

April 8, 2014 | Tuesday | News
Latanoprost improves glucose, lipid disorder in diabetes

Singapore: Researchers from Shanghai Institute of Materia Medica, Chinese Academy of Science, have discovered that Latan...

September 9, 2013 | Monday | News
QRxPharma refiles Moxduo NDA with FDA

Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...

November 26, 2013 | Tuesday | News
Eli Lilly partners with BioNTech to develop cancer immunotherapies

Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...

May 12, 2015 | Tuesday | News
Boehringer Ingelheim collaborates with Harvard University

Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...

July 10, 2012 | Tuesday | News
Zydus Cadila launches indigenous diabetes drug

Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...

September 20, 2013 | Friday | News
Astellas receives approval of Irribow in Japan

Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...

August 19, 2013 | Monday | News
Biotron to report data from hepatitis C trial

Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...

October 16, 2012 | Tuesday | News
Biocon's novel anti-psoriasis biotech drug Itolizumab released in India

After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...

August 12, 2013 | Monday | News
Bioventus gets global rights for Pfizer's bone portfolio

Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...

July 4, 2013 | Thursday | News
Merck to halt Parkinson's trial due to lack of efficacy

Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...

May 27, 2013 | Monday | News
Hong Kong to host international TCM exhibition, conference

Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...

August 12, 2013 | Monday | News